The Nutrient-Dependent O-GlcNAc Modification Controls the Expression of Liver Fatty Acid Synthase

Journal of Molecular Biology

Volumn 428, Issue 16, 2016, Pages 3295-3304

  Baldini, Steffi F ^a   Wavelet, Cindy ^a   Hainault, Isabelle ^b   Guinez, Céline ^c   Lefebvre, Tony ^a  

^a UNIV LILLE   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c UNIVERSITÉ DE LILLE   (France)

Author keywords

FAS; lipogenesis; liver; O GlcNAcylation; ob ob mice

Indexed keywords

DEUBIQUITINASE; FATTY ACID; FATTY ACID SYNTHASE; GLYCOSIDASE INHIBITOR; N ACETYL BETA GLUCOSAMINIDASE; N ACETYLGLUCOSAMINE; N ACETYLGLUCOSAMINYLTRANSFERASE; THIAMET G; UBIQUITIN SPECIFIC PROTEASE 2A; UNCLASSIFIED DRUG; O-GLCNAC TRANSFERASE;

ACYLATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE DIET; CONTROLLED STUDY; CORRELATIONAL STUDY; ENZYME INHIBITION; EX VIVO STUDY; FATTY ACID SYNTHESIS; HEPG2 CELL LINE; HUMAN; HUMAN CELL; IN VIVO STUDY; LIVER; MALE; MOUSE; NONHUMAN; NUTRIENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; ANIMAL; C57BL MOUSE; CELL LINE; FOOD; LIPOGENESIS; METABOLISM; OBESITY; PHYSIOLOGY;

ANIMALS; CELL LINE; FATTY ACID SYNTHASES; FOOD; LIPOGENESIS; LIVER; MICE; MICE, INBRED C57BL; N-ACETYLGLUCOSAMINYLTRANSFERASES; OBESITY; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84969962012     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2016.04.035     Document Type: Article

References (34)

1. [1] Calder, P.C., Functional roles of fatty acids and their effects on human health. J. Parenter. Enter. Nutr. 39 (2015), 18S–32S.
2. [2] Girard, J., Perdereau, D., Foufelle, F., Prip-Buus, C., Ferré, P., Regulation of lipogenic enzyme gene expression by nutrients and hormones. FASEB J. 8 (1994), 36–42.
3. [3] Donnelly, K.L., Smith, C.I., Schwarzenberg, S.J., Jessurun, J., Boldt, M.D., Parks, E.J., Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J. Clin. Invest. 115 (2005), 1343–1351.
4. [4] Marshall, S., Bacote, V., Traxinger, R.R., Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J. Biol. Chem. 266 (1991), 4706–4712.
5. [5] Hanover, J.A., Krause, M.W., Love, D.C., The hexosamine signaling pathway: O-GlcNAc cycling in feast or famine. Biochim. Biophys. Acta. 1800 (2010), 80–95.
6. [6] Torres, C.R., Hart, G.W., Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc. J. Biol. Chem. 259 (1984), 3308–3317.
7. [7] Kreppel, L.K., Blomberg, M.A., Hart, G.W., Dynamic glycosylation of nuclear and cytosolic proteins. Cloning and characterization of a unique O-GlcNAc transferase with multiple tetratricopeptide repeats. J. Biol. Chem. 272 (1997), 9308–9315.
8. [8] Hu, Y., Suarez, J., Fricovsky, E., Wang, H., Scott, B.T., Trauger, S.A., et al. Increased enzymatic O-GlcNAcylation of mitochondrial proteins impairs mitochondrial function in cardiac myocytes exposed to high glucose. J. Biol. Chem. 284 (2009), 547–555.
9. [9] Gao, Y., Wells, L., Comer, F.I., Parker, G.J., Hart, G.W., Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic beta-N-acetylglucosaminidase from human brain. J. Biol. Chem. 276 (2001), 9838–9845.
10. [10] Lefebvre, T., Dehennaut, V., Guinez, C., Olivier, S., Drougat, L., Mir, A.-M., et al. Dysregulation of the nutrient/stress sensor O-GlcNAcylation is involved in the etiology of cardiovascular disorders, type-2 diabetes and Alzheimer's disease. Biochim. Biophys. Acta. 1800 (2010), 67–79.
11. [11] Ruan, H.B., Singh, J.P., Li, M.D., Wu, J., Yang, X., Cracking the O-GlcNAc code in metabolism. Trends Endocrinol. Metab. 24 (2013), 301–309.
12. [12] Ruan, H.B., Dietrich, M.O., Liu, Z.W., Zimmer, M.R., Li, M.D., Singh, J.P., et al. O-GlcNAc transferase enables AgRP neurons to suppress browning of white fat. Cell. 159 (2014), 306–317.
13. [13] Denechaud, P.-D., Dentin, R., Girard, J., Postic, C., Role of ChREBP in hepatic steatosis and insulin resistance. FEBS Lett. 582 (2008), 68–73.
14. [14] Guinez, C., Filhoulaud, G., Rayah-Benhamed, F., Marmier, S., Dubuquoy, C., Dentin, R., et al. O-GlcNAcylation increases ChREBP protein content and transcriptional activity in the liver. Diabetes. 60 (2011), 1399–1413.
15. [15] Sakiyama, H., Fujiwara, N., Noguchi, T., Eguchi, H., Yoshihara, D., Uyeda, K., Suzuki, K., The role of O-linked GlcNAc modification on the glucose response of ChREBP. Biochem. Biophys. Res. Commun. 402 (2010), 784–789.
16. [16] Repa, J.J., Liang, G., Ou, J., Bashmakov, Y., Lobaccaro, J.M., Shimomura, I., et al. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Genes Dev. 14 (2000), 2819–2830.
17. [17] Cha, J.-Y., Repa, J.J., The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR. J. Biol. Chem. 282 (2007), 743–751.
18. [18] Diraison, F., Motakis, E., Parton, L.E., Nason, G.P., Leclerc, I., Rutter, G.A., Impact of adenoviral transduction with SREBP1c or AMPK on pancreatic islet gene expression profile: analysis with oligonucleotide microarrays. Diabetes. 53 (2004), S84–591.
19. [19] Bindesbøll, C., Fan, Q., Nørgaard, R.C., MacPherson, L., Ruan, H.-B., Wu, J., et al. Liver X receptor regulates hepatic nuclear O-GlcNAc signaling and carbohydrate responsive element-binding protein activity. J. Lipid Res. 56 (2015), 771–785.
20. [20] Anthonisen, E.H., Berven, L., Holm, S., Nygård, M., Nebb, H.I., Grønning-Wang, L.M., Nuclear receptor liver X receptor is O-GlcNAc-modified in response to glucose. J. Biol. Chem. 285 (2010), 1607–1615.
21. [21] Shen, L.-L., Liu, H., Peng, J., Gan, L., Lu, L., Zhang, Q., et al. Effects of farnesoid X receptor on the expression of the fatty acid synthetase and hepatic lipase. Mol. Biol. Rep. 38 (2011), 553–559.
22. [22] Berrabah, W., Aumercier, P., Gheeraert, C., Dehondt, H., Bouchaert, E., Alexandre, J., et al. Glucose sensing O-GlcNAcylation pathway regulates the nuclear bile acid receptor farnesoid X receptor (FXR). Hepatology. 59 (2014), 2022–2033.
23. [23] Ruan, H.-B., Nie, Y., Yang, X., Regulation of protein degradation by O-GlcNAcylation: crosstalk with ubiquitination. Mol. Cell. Proteomics. 12 (2013), 3489–3497.
24. [24] Olivier-Van Stichelen, S., Dehennaut, V., Buzy, A., Zachayus, J.-L., Guinez, C., Mir, A.-M., et al. O-GlcNAcylation stabilizes β-catenin through direct competition with phosphorylation at threonine 41. FASEB J. 28 (2014), 3325–3338.
25. [25] Ruan, H.-B., Han, X., Li, M.-D., Singh, J.P., Qian, K., Azarhoush, S., et al. O-GlcNAc transferase/host cell factor C1 complex regulates gluconeogenesis by modulating PGC-1α stability. Cell Metab. 16 (2012), 226–237.
26. [26] Park, S.Y., Kim, H.S., Kim, N.H., Ji, S., Cha, S.Y., Kang, J.G., et al. Snail1 is stabilized by O-GlcNAc modification in hyperglycaemic condition. EMBO J. 29 (2010), 3787–3796.
27. [27] Ding, X., Jiang, W., Zhou, P., Liu, L., Wan, X., Yuan, X., et al. Mixed lineage leukemia 5 (MLL5) protein stability is cooperatively regulated by O-GlcNAc transferase (OGT) and ubiquitin specific protease 7 (USP7). PLoS One, 10(12), 2015, e0145023, 10.1371/journal.pone.0145023.
28. [28] Zheng, G., Lin, L., Zhong, S., Zhang, Q., Li, D., Effects of puerarin on lipid accumulation and metabolism in high-fat diet-fed mice. PLoS One, 10(3), 2015, e0122925, 10.1371/journal.pone.0122925.
29. [29] An, Z., Wang, H., Song, P., Zhang, M., Geng, X., Zou, M.-H., Nicotine-induced activation of AMP-activated protein kinase inhibits fatty acid synthase in 3T3L1 adipocytes a ROLE FOR OXIDANT STRESS. J. Biol. Chem. 282 (2007), 26,793–26,801.
30. [30] Jin, Q., Yuan, L.X., Boulbes, D., Baek, J.M., Wang, Y.N., Gomez-Cabello, D., et al. Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells. Breast Cancer Res., 12, 2010, R96.
31. [31] Perez-Cervera, Y., Dehennaut, V., Aquino Gil, M., Guedri, K., Solórzano Mata, C.J., Olivier-Van Stichelen, S., et al. Insulin signaling controls the expression of O-GlcNAc transferase and its interaction with lipid microdomains. FASEB J. 27 (2013), 3478–3486.
32. [32] Baldini, S.F., Lefebvre, T., O-GlcNAcylation and the metabolic shift in high-proliferating cells: all the evidence suggests that sugars dictate the flux of lipid biogenesis in tumor processes. Front. Oncol., 6, 2016, 6.
33. [33] Graner, E., Tang, D., Rossi, S., Baron, A., Migita, T., Weinstein, L.J., et al. The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer. Cancer Cell. 5 (2004), 253–261.
34. [34] Priolo, C., Tang, D., Brahamandan, M., Benassi, B., Sicinska, E., Ogino, S., et al. The isopeptidase USP2a protects human prostate cancer from apoptosis. Cancer Res. 66 (2006), 8625–8632.